
Galera
Discovering and developing novel mechanism-based therapies that have the potential to improve both treatment and outcomes for patients with cancer.
Market cap
$1.6m
Enterprise value
($2m)
Share price
$0.02 GRTX
Authorizing premium user...
Discovering and developing novel mechanism-based therapies that have the potential to improve both treatment and outcomes for patients with cancer.